DEAN ZIMMERMANN: Open Payments
NPI 1417580416 · SAINT AUGUSTINE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$808 in 30 payments from 17 companies in 2025. Trend: 2023 $82 · 2024 $173 · 2025 $808
Food & beverage: $808
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $171 |
| Merck Sharp & Dohme LLC | 3 | $82 |
| TOLMAR, INC. | 3 | $73 |
| Novartis Pharmaceuticals Corporation | 2 | $66 |
| Boston Scientific Corporation | 1 | $57 |
| UROGEN PHARMA, INC. | 2 | $53 |
| Dendreon Pharmaceuticals LLC | 2 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| Teleflex LLC | 1 | $28 |
Products named: XTANDI, KEYTRUDA, JATENZO, PLUVICTO, LithoVue, PROVENGE, Nubeqa, ORGOVYX.
Industry payments across FL — which companies pay providers there.
